Quanex Building Products Announces Third Quarter 2026 Results

GlobeNewswire | Quanex Building Products Corporation
Today at 8:15pm UTC

Net Sales Growth
Volumes Continue to Track Normal Seasonality Patterns
Margin Expansion Realized in Hardware Solutions Segment and on Consolidated Basis
$42.25 Million of Debt Repaid in 3Q26
Continued Progress and Execution on Working Capital Management

HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2026.  

The Company reported the following selected financial results:

  Three Months Ended July 31, Nine Months Ended July 31,
($ in millions, except per share data) 2026 2025 2026 2025
Net Sales $501.8 $495.3 $1,373.3 $1,347.8
Gross Margin $141.5 $138.0 $357.8 $361.7
Gross Margin % 28.2% 27.9% 26.1% 26.8%
Operating Income (Loss) $46.5 ($270.8) $68.1 ($236.9)
Net Income (Loss) $26.5 ($276.0) $25.8 ($270.4)
Diluted EPS $0.58 ($6.04) $0.57 ($5.83)
         
Adjusted Net Income $36.0 $31.6 $47.0 $68.4
Adjusted Diluted EPS $0.79 $0.69 $1.03 $1.47
Adjusted EBITDA $72.7 $70.3 $144.3 $172.0
Adjusted EBITDA Margin % 14.5% 14.2% 10.5% 12.8%
         
Cash Provided By Operating Activities $58.6 $60.7 $57.3 $76.6
Free Cash Flow $47.8 $46.2 $24.2 $35.6
         

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, stated, “Volumes continued to track normal seasonality patterns during the third quarter of 2026, and we made meaningful progress addressing the price versus cost imbalance that impacted our margins in the second quarter of 2026. Inflationary pressures related to macroeconomic concerns and the ongoing conflict in the Middle East are still having an impact, but the initial rate and magnitude of these pressures have somewhat subsided.

“We stayed focused on managing our working capital during the third quarter of 2026, which when coupled with the seasonal uptick in volumes, enabled us to repay $42.25 million of debt and buy back some of our shares. We will continue to prioritize repaying debt and opportunistically repurchasing our shares as we generate cash in the fourth quarter of 2026. In addition, we will continue to identify operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence and demand improve.”

Third Quarter 2026 Results Summary   

Quanex reported net sales of $501.8 million during the three months ended July 31, 2026, which represents an increase of 1.3% compared to $495.3 million for the same period in 2025, mainly due to favorable impacts from pricing, partially offset by the impact of IEEPA tariff reimbursements to customers. The Hardware Solutions segments reported a 2.7% decline in net sales for the third quarter of 2026, driven by lower volumes and the impact of IEEPA tariff reimbursements to customers, which were somewhat offset by favorable impacts from pricing. The Extruded Solutions segments reported net sales growth of 2.8% for the third quarter of 2026, as lower volumes were more than offset by favorable impacts from pricing. Quanex reported an increase of 8.5% in net sales for the third quarter of 2026 in its Custom Solutions segment, largely due to increased volume and improved pricing. (See Sales Analysis table for additional information)

On a consolidated basis, the increase in reported earnings for the third quarter of 2026 compared to the third quarter of 2025 was mainly due to improved pricing, lower depreciation and amortization expense and lower interest expense. Results for the third quarter of 2025 were also impacted by a $302.3 million non-cash goodwill impairment.

Balance Sheet & Liquidity Update

As of July 31, 2026, the Company had total debt of $672.2 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was 2.8x. As of July 31, 2026, Quanex reported LTM Net Income of $45.4 million and LTM Adjusted EBITDA of $215.2 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity increased by 10.5% to $363.1 million as of July 31, 2026, consisting of $62.1 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 99,786 shares of common stock for approximately $1.7 million at an average price of $17.10 per share during the three months ended July 31, 2026. As of July 31, 2026, approximately $28.7 million remained under the existing share repurchase authorization.   

Conference Call and Webcast Information

The Company has scheduled a conference call for Friday, September 4, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link:
https://register-conf.media-server.com/register/BIac7900426be941999342c141e5049229

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently partners with leading OEMs to provide innovative solutions in window, door, solar, refrigeration, custom mixing, building access and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflect operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  These measures allow management and investors to evaluate operational performance and trends without the impact of certain non-cash charges, acquisition-related costs, and other items that may vary significantly from period to period and may not be reflective of Quanex’s core operating results. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.   Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” “anticipate,” “intend,” “plan,” “project,” “seek,” “would,” “may,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, expectations regarding the recovery of price versus cost imbalances, anticipated debt repayment and share repurchase activity, expected operational efficiencies and synergies and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from those expressed or implied in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

 
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
         
  Three Months Ended July 31, Nine Months Ended July 31,
  2026
 2025
 2026
 2025
         
Net sales $501,845  $495,273  $1,373,301  $1,347,795 
Cost of sales  360,380   357,305   1,015,517   986,129 
Selling, general and administrative  70,837   71,270   216,695   208,253 
Restructuring charges  -   1,367   -   10,207 
Depreciation and amortization  24,138   33,882   73,037   77,814 
Asset impairment charges  -   302,284   -   302,284 
Operating income (loss)  46,490   (270,835)  68,052   (236,892)
Interest expense  (11,978)  (14,218)  (36,387)  (42,344)
Other, net  (93)  855   5,972   1,925 
Income (loss) before income taxes  34,419   (284,198)  37,637   (277,311)
Income tax (expense) benefit  (7,915)  8,191   (11,854)  6,934 
Net income (loss) $26,504  $(276,007) $25,783  $(270,377)
         
Earnings (loss) per common share, basic $0.58  $(6.04) $0.57  $(5.83)
Earnings (loss) per common share, diluted $0.58  $(6.04) $0.57  $(5.83)
         
Weighted average common shares outstanding:       
Basic  45,461   45,691   45,466   46,395 
Diluted  45,648   45,691   45,607   46,395 
         
Cash dividends per share $0.08  $0.08  $0.24  $0.24 
         


 
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
     
  July 31, 2026 October 31, 2025
ASSETS    
Current assets:    
Cash and cash equivalents $62,094  $76,018 
Restricted Cash  2,123   2,100 
Accounts receivable, net  214,768   205,384 
Inventories  276,396   254,122 
Income taxes receivable  5,603   - 
Prepaid assets  37,452   32,387 
Other current assets  3,847   3,764 
Total current assets  602,283   573,775 
Property, plant and equipment, net  394,021   411,591 
Operating lease right-of-use assets  171,552   154,866 
Deferred tax assets  300   2,706 
Goodwill  273,765   271,346 
Intangible assets, net  522,218   549,137 
Other assets  4,552   4,812 
Total assets $1,968,691  $1,968,233 
     
LIABILITIES AND STOCKHOLDERS' EQUITY    
Current liabilities:    
Accounts payable $127,030  $131,307 
Accrued liabilities  88,209   95,155 
Income taxes payable  9,300   12,076 
Current maturities of long-term debt  26,551   27,561 
Current operating lease liabilities  18,822   15,446 
Other liabilities  -   - 
Total current liabilities  269,912   281,545 
Long-term debt  636,814   665,268 
Noncurrent operating lease liabilities  160,290   145,459 
Deferred pension benefits    
Deferred income taxes  137,766   135,993 
Liabilities for uncertain tax positions  1,857   - 
Other liabilities  16,608   13,789 
Total liabilities  1,223,247   1,242,054 
Stockholders’ equity:    
Common stock  512   512 
Additional paid-in-capital  697,598   700,029 
Retained earnings  179,472   164,710 
Accumulated other comprehensive loss  (32,142)  (35,439)
Treasury stock at cost  (99,996)  (103,633)
Total stockholders’ equity  745,444   726,179 
Total liabilities and stockholders' equity $1,968,691  $1,968,233 
     


 
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
    
 Nine Months Ended July 31,
 2026
 2025
Operating activities:   
Net (loss) income$25,783  $(270,377)
Adjustments to reconcile net loss to cash used for operating activities:   
Depreciation and amortization 73,037   77,814 
Stock-based compensation 3,617   2,762 
Deferred income tax 664   (26,440)
Goodwill impairment charge -   302,284 
Other, net 4,640   9,203 
Changes in assets and liabilities:   
Increase in accounts receivable (8,685)  (1,727)
(Increase) decrease in inventory (21,129)  5,261 
Increase in other current assets (4,430)  (7,228)
(Decrease) increase in accounts payable (2,365)  144 
Decrease in accrued liabilities (7,601)  (9,725)
Change in income taxes (6,629)  (21)
Other, net 366   (5,307)
Cash provided by operating activities 57,268   76,643 
Investing activities:   
Capital expenditures (33,066)  (40,996)
Proceeds from disposition of capital assets 62   361 
Cash used for investing activities (33,004)  (40,635)
Financing activities:   
Borrowings under credit facilities 141,500   170,000 
Repayments of credit facility borrowings (164,250)  (213,750)
Repayments of other long-term debt (3,316)  (1,962)
Common stock dividends paid (10,916)  (11,233)
Purchase of treasury stock (1,707)  (29,248)
Other, net (704)  (1,186)
Cash used for financing activities (39,393)  (87,379)
Effect of exchange rate changes on cash and cash equivalents 1,228   16,302 
Decrease in cash, cash equivalents and restricted cash (13,901)  (35,069)
Cash, cash equivalents and restricted cash at beginning of period 78,118   102,995 
Cash, cash equivalents and restricted cash at end of period$64,217  $67,926 
    


 
QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
            
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.
        
 Three Months Ended July 31,
 Nine Months Ended July 31,
 2026
 2025
 2026
 2025
Cash provided by operating activities$58,554  $60,656  $57,268  $76,643 
Capital expenditures(10,744) (14,452) (33,066) (40,996)
Free Cash Flow$47,810  $46,204  $24,202  $35,647 
            
            
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
            
 As of July 31,
    
 2026
 2025
      
Term loan facility$450,000  $475,000       
Revolving credit facility168,500  197,500       
Finance lease obligations (1)53,697  61,194       
Total debt (2)672,197  733,694       
Less: Cash and cash equivalents62,094  66,272       
Net Debt$610,103  $667,422       
            
(1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively.
(2) Excludes outstanding letters of credit.
            


 
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)
            
Reconciliation of Last Twelve Months Adjusted EBITDA Three Months Ended July 31, 2026
 Three Months Ended April 30, 2026 Three Months Ended January 31, 2026 Three Months Ended October 31, 2025 Total
  Reconciliation
 Reconciliation Reconciliation Reconciliation Reconciliation
Net income (loss) as reported $26,504  $3,350  $(4,071) $19,571  $45,354 
Income tax expense (benefit)  7,915   3,766   173   15,147   27,001 
Other, net  93   (448)  (5,617)  (5,246)  (11,218)
Interest expense  11,978   12,042   12,367   13,468   49,855 
Depreciation and amortization  24,138   24,650   24,249   25,630   98,667 
EBITDA  70,628   43,360   27,101   68,570   209,659 
Cost of sales (1)  1,223   121   407   308   2,059 
Selling, general and administrative (1),(2)  894   688   (126)  2,040   3,496 
Adjusted EBITDA $72,745  $44,169  $27,382  $70,918  $215,214 
            
(1) Severance and other expenses related to manufacturing footprint and performance optimization.
(2) Transaction, advisory fees, severance and reorganization costs.
            


 
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
                  
Reconciliation of Adjusted Net Income and Adjusted EPS Three Months Ended July 31, 2026 Three Months Ended July 31, 2025 Nine Months Ended July 31, 2026 Nine Months Ended July 31, 2025 
  Net Income Diluted EPS Net Income Diluted EPS Net Income Diluted EPS Net Income Diluted EPS 
Net income (loss) as reported $26,504  $0.58  $(276,007) $(6.04) $25,783  $0.57  $(270,377) $(5.83) 
Net income(loss) reconciling items from below  9,507  $0.21   307,578  $6.73   21,221  $0.46   338,756  $7.30  
Adjusted net income and adjusted EPS $36,011  $0.79  $31,571  $0.69  $47,004  $1.03  $68,379  $1.47  
                  
Reconciliation of Adjusted EBITDA Three Months Ended July 31, 2026 Three Months Ended July 31, 2025 Nine Months Ended July 31, 2026 Nine Months Ended July 31, 2025 
  Reconciliation   Reconciliation   Reconciliation   Reconciliation   
Net income (loss) as reported $26,504    $(276,007)   $25,783    $(270,377)   
Income tax expense  7,915     (8,191)    11,854     (6,934)   
Other, net  93     (855)    (5,972)    (1,925)   
Interest expense  11,978     14,218     36,387     42,344    
Depreciation and amortization  24,138     33,882     73,037     77,814    
Asset impairment charges  -     302,284     -     302,284    
EBITDA  70,628     65,331     141,089     143,206    
EBITDA reconciling items from below  2,117     4,964     3,207     28,766    
Adjusted EBITDA $72,745    $70,295    $144,296    $171,972    
                  
Reconciling Items Three Months Ended July 31, 2026 Three Months Ended July 31, 2025 Nine Months Ended July 31, 2026 Nine Months Ended July 31, 2025 
  Income Statement Reconciling Items Income Statement Reconciling Items Income Statement Reconciling Items Income Statement Reconciling Items 
Net sales $501,845  $-  $495,273  $-  $1,373,301  $-  $1,347,795  $-  
Cost of sales  360,380   (1,223)(1) 357,305   (148)(1) 1,015,517   (1,751)(1) 986,129   (1,124)(1)
Selling, general and administrative  70,837   (894)(1),(3) 71,270   (3,449)(1),(3) 216,695   (1,456)(1),(3) 208,253   (17,435)(1),(2),(3)
Restructuring charges  -   -   1,367   (1,367)(4) -   -   10,207   (10,207)(4)
EBITDA  70,628   2,117   65,331   4,964   141,089   3,207   143,206   28,766  
Asset impairment charges  -   -   302,284   (302,284)(5) -   -   302,284   (302,284)(5)
Depreciation and amortization  24,138   (9,758)(6) 33,882   (19,604)(6) 73,037   (29,291)(6) 77,814   (36,708)(6)
Operating income (loss)  46,490   11,875   (270,835)  326,852   68,052   32,498   (236,892)  367,758  
Interest expense  (11,978)  -   (14,218)  -   (36,387)  -   (42,344)  -  
Other, net  (93)  288 (7) 855   (949)(7) 5,972   (4,942)(7) 1,925   (118)(7)
Income (loss) before income taxes  34,419   12,163   (284,198)  325,903   37,637   27,556   (277,311)  367,640  
Income tax (expense) benefit  (7,915)  (2,656)(8) 8,191   (18,325)(8) (11,854)  (6,335)(8) 6,934   (28,884)(8)
Net income (loss) $26,504   9,507  $(276,007) $307,578  $25,783   21,221  $(270,377) $338,756  
                  
Diluted earnings (loss) per share $0.58    $(6.04)   $0.57    $(5.83)   
                  
                  
(1) Severance and other expenses related to manufacturing footprint and performance optimization.
(2) Amortization of step-up for purchase price adjustments on inventory.
(3) Transaction, advisory fees, and severance and reorganization costs.
(4) Restructuring charges related to severance and disposal of software.
(5) Goodwill impairment.
(6) Amortization expense related to intangible assets.
(7) Foreign currency transaction (gains) losses.
(8) Tax impact of net income reconciling items.
                  


 
QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
           
This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.
           
  Hardware Solutions Extruded Solutions Custom Solutions Unallocated Corp & Other Total
Three months ended July 31, 2026          
Net sales $220,923  $179,291  $111,007  $(9,376) $501,845 
Cost of sales  162,056   121,389   85,861   (8,926)  360,380 
Gross Margin  58,867   57,902   25,146   (450)  141,465 
Gross Margin %  26.6%  32.3%  22.7%    28.2%
Selling, general and administrative (1)  33,162   22,279   13,143   2,253   70,837 
Depreciation and amortization  11,386   7,213   5,330   209   24,138 
Operating (loss) income  14,319   28,410   6,673   (2,912)  46,490 
Depreciation and amortization  11,386   7,213   5,330   209   24,138 
EBITDA  25,705   35,623   12,003   (2,703)  70,628 
Expense related to plant relocation and closure (Cost of sales)  1,223   -   -   -   1,223 
Reorganization and severance costs  127   1   -   766   894 
Adjusted EBITDA $27,055  $35,624  $12,003  $(1,937) $72,745 
Adjusted EBITDA Margin %  12.2%  19.9%  10.8%    14.5%
           
Three months ended July 31, 2025          
Net sales $227,116  $174,427  $102,264  $(8,534) $495,273 
Cost of sales  170,282   116,597   77,755   (7,329)  357,305 
Gross Margin  56,834   57,830   24,509   (1,205)  137,968 
Gross Margin %  25.0%  33.2%  24.0%    27.9%
Selling, general and administrative (1)  32,954   20,740   11,708   5,868   71,270 
Restructuring charges  1,140   34   26   167   1,367 
Depreciation and amortization  16,987   6,989   4,716   5,190   33,882 
Asset impairment charges  163,198   54,934   84,152   -   302,284 
Operating income (loss)  (157,445)  (24,867)  (76,093)  (12,430)  (270,835)
Depreciation and amortization  16,987   6,989   4,716   5,190   33,882 
Asset impairment charges  163,198   54,934   84,152   -   302,284 
EBITDA  22,740   37,056   12,775   (7,240)  65,331 
Expense related to plant relocation and closure (Cost of sales)  148   -   -   -   148 
Transaction, advisory fees, reorganization costs, and product recall expenses  715   -   50   2,684   3,449 
Restructuring charges  1,140   34   26   167   1,367 
Adjusted EBITDA $24,743  $37,090  $12,851  $(4,389) $70,295 
Adjusted EBITDA Margin %  10.9%  21.3%  12.6%    14.2%
           
Nine months ended July 31, 2026          
Net sales $613,054  $484,040  $304,062  $(27,855) $1,373,301 
Cost of sales  475,172   331,979   236,302   (27,936)  1,015,517 
Gross Margin  137,882   152,061   67,760   81   357,784 
Gross Margin %  22.5%  31.4%  22.3%    26.1%
Selling, general and administrative (1)  103,105   65,084   40,182   8,324   216,695 
Depreciation and amortization  34,626   21,893   15,956   562   73,037 
Operating (loss) income  151   65,084   11,622   (8,805)  68,052 
Depreciation and amortization  34,626   21,893   15,956   562   73,037 
EBITDA  34,777   86,977   27,578   (8,243)  141,089 
Expense related to plant relocation and closure (Cost of sales)  1,751   -   -   -   1,751 
Credit related to plant relocation (SG&A)  (8)  -   -   -   (8)
Reorganization and severance costs  273   1   1   1,189   1,464 
Adjusted EBITDA $36,793  $86,978  $27,579  $(7,054) $144,296 
Adjusted EBITDA Margin %  6.0%  18.0%  9.1%    10.5%
           
Nine months ended July 31, 2025          
Net sales $614,791  $478,024  $284,809  $(29,829) $1,347,795 
Cost of sales  466,600   325,914   219,755   (26,140)  986,129 
Gross Margin  148,191   152,110   65,054   (3,689)  361,666 
Gross Margin %  24.1%  31.8%  22.8%    26.8%
Selling, general and administrative (1)  98,570   60,921   34,156   14,606   208,253 
Restructuring charges  8,155   34   26   1,992   10,207 
Depreciation and amortization  38,818   22,066   15,693   1,237   77,814 
Asset impairment charges  163,198   54,934   84,152   -   302,284 
Operating (loss) income  (160,550)  14,155   (68,973)  (21,524)  (236,892)
Depreciation and amortization  38,818   22,066   15,693   1,237   77,814 
Asset impairment charges  163,198   54,934   84,152   -   302,284 
EBITDA  41,466   91,155   30,872   (20,287)  143,206 
Expense related to plant closure (Cost of sales)  1,124   -   -   -   1,124 
Gain related to plant closure (SG&A)  247   -   -   -   247 
Amortization of step-up for purchase price adjustments on inventory and accounts receivable  7,276   1,428   302   -   9,006 
Transaction and advisory fees  1,397   177   50   6,558   8,182 
Restructuring charges  8,155   34   26   1,992   10,207 
Adjusted EBITDA $59,665  $92,794  $31,250  $(11,737) $171,972 
Adjusted EBITDA Margin %  9.7%  19.4%  11.0%    12.8%
           
(1) Includes stock-based compensation expense for the three and nine months ended July 31 2026 of $0.9 million and 5.5 million, respectively, and $1.8 million and $3.6 million for the comparable prior year periods.
           


 
QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
         
  Three Months Ended July 31,
 Nine Months Ended July 31,
  2026
 2025
 2026
 2025
         
Hardware Solutions:(1)       
 Window and door hardware$133,038  $148,303  $387,047  $405,497 
 Screens 85,830   76,809   219,980   203,269 
 Other 2,055   2,004   6,027   6,025 
  $220,923  $227,116  $613,054  $614,791 
Extruded Solutions:(2)       
 Window profiles$75,684  $76,775  $206,581  $206,629 
 Seals and gaskets 20,241   20,415   57,405   57,857 
 Spacers 59,996   55,201   160,124   148,733 
 Solar 5,375   5,250   15,292   17,835 
 Flashing Tape 2,821   3,038   7,567   6,751 
 Window and door hardware 10,079   10,676   26,061   31,311 
 Other 5,095   3,072   11,010   8,908 
  $179,291  $174,427  $484,040  $478,024 
Custom Solutions:(3)       
 Wood solutions$59,282  $53,409  $162,841  $148,456 
 Access solutions 29,483   27,370   78,984   74,158 
 Mixing solutions 22,242   21,485   62,237   62,195 
  $111,007  $102,264  $304,062  $284,809 
         
Unallocated Corporate & Other:       
 Eliminations$(9,376) $(8,534) $(27,855) $(29,829)
  $(9,376) $(8,534) $(27,855) $(29,829)
         
Net Sales$501,845  $495,273  $1,373,301  $1,347,795 
         
(1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.
(2) Reflects an unfavorable $0.1 million and favorable $8.3 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.
(3) Reflects no impact and favorable $0.3 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.
 



Primary Logo